Orthostatic Hypercoagulability: A Novel Physiological Mechanism to Activate the Coagulation System

Orthostatic stress causes significant plasma shift and raises transmural pressure in lower extremities, resulting in an increase in endothelial activation and plasma proteins concentrations, possibly including coagulation factors. This may lead to activation of the coagulation system during standing. To test this hypothesis, we recruited 18 healthy volunteers (9 females and 9 males; mean age: 25±1.2 years; body mass index: 21.7±0.5 kg/m2). Hemodynamics, plasma shift (extrapolated from sequential hematocrit concentration), plasma proteins, and coagulation tests, including procoagulants; fibrinogen, factor V, and factor VIII activity; prothrombin fragments 1 and 2; and endothelial activation–related factors (tissue factor and von Willebrand factor), as well as protein C global pathway, were determined at rest supine and at 15 minutes, 30 minutes, and 60 minutes of still standing. Thirty minutes of standing caused a decrease in plasma volume by 12.0±0.5% and an increase in plasma protein by 13.0±0.7%. Fibrinogen, factor V, and factor VIII activity rose by 12.0±1.2%, 13.0±1.0%, and 40.0±6.0% (P<0.002 for all), respectively. Prothrombin fragments 1 and 2 were elevated by 150.0±30.0%. Tissue factor and von Willebrand factor increased by 30.0±9.0% and 17.4±51.0% (P<0.02 for both), respectively. However, protein C assay results decreased from 0.95±0.20 to 0.83±0.16 (P<0.001). We hereby introduce a novel physiological mechanism, “orthostatic procoagulation,” that should be considered during coagulation tests. Furthermore, it could be extrapolated to the pathophysiology of stasis and venous thromboembolism.

[1]  J. Dormandy Clinical significance of blood viscosity. , 1970, Annals of the Royal College of Surgeons of England.

[2]  Dormandy Ja Clinical significance of blood viscosity. , 1970 .

[3]  S. Horvath,et al.  Plasma volume changes with movement to supine and standing positions. , 1978, Journal of applied physiology: respiratory, environmental and exercise physiology.

[4]  L V McIntire,et al.  Characteristics of shear-induced aggregation in whole blood. , 1984, The Journal of laboratory and clinical medicine.

[5]  McIntire Lv,et al.  Characteristics of shear-induced aggregation in whole blood. , 1984 .

[6]  M. Moser,et al.  Fluid and protein shifts after postural changes in humans. , 1986, The American journal of physiology.

[7]  E. Bassenge,et al.  Endothelial function in different organs. , 1996, Progress in cardiovascular diseases.

[8]  P. Norsk,et al.  Adaptation of plasma volume in humans to prolonged head-down bed rest. , 1996, Journal of gravitational physiology : a journal of the International Society for Gravitational Physiology.

[9]  P. Persson Modulation of cardiovascular control mechanisms and their interaction. , 1996, Physiological reviews.

[10]  S. Chien,et al.  Shear stress induction of the tissue factor gene. , 1997, The Journal of clinical investigation.

[11]  F. Dati,et al.  ProC Global: the first functional screening assay for the complete protein C pathway. , 1997, Clinical chemistry.

[12]  G. Remuzzi,et al.  Fluid shear stress modulates von Willebrand factor release from human vascular endothelium. , 1997, Blood.

[13]  R Furlan,et al.  Effect of standing on neurohumoral responses and plasma volume in healthy subjects. , 1998, Journal of applied physiology.

[14]  S. Nakamura,et al.  Expression of functional tissue factor on small vesicles of lipopolysaccharide-stimulated human vascular endothelial cells. , 1998, Thrombosis research.

[15]  J. Muller,et al.  Upright posture and maximal exercise increase platelet aggregability and prostacyclin production in healthy male subjects. , 1999, British journal of sports medicine.

[16]  W. Aird,et al.  Vascular-bed--specific hemostasis and hypercoagulable states. , 1999, The New England journal of medicine.

[17]  Partial thromboplastin time: prediction of adverse events and poor prognosis by low abnormal values. , 1999, Archives of internal medicine.

[18]  M. Hitosugi,et al.  Rheologic changes in venous blood during prolonged sitting. , 2000, Thrombosis research.

[19]  C. Wollheim,et al.  Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP. , 2000, The Journal of clinical investigation.

[20]  J. Hathcock,et al.  Active tissue factor shed from human arterial smooth muscle cells adheres to artificial surfaces , 2000, Journal of biomaterials science. Polymer edition.

[21]  P. Toulon,et al.  Sensitivity of the ProC global assay for protein C pathway abnormalities. clinical experience in 899 unselected patients with venous thromboembolism. , 2001, Thrombosis research.

[22]  D. Monroe,et al.  A Cell-based Model of Hemostasis , 2001, Thrombosis and Haemostasis.

[23]  F Lapostolle,et al.  Severe pulmonary embolism associated with air travel. , 2001, The New England journal of medicine.

[24]  L. Mazzolai,et al.  Tissue Factor Activity Is Upregulated in Human Endothelial Cells Exposed to Oscillatory Shear Stress , 2002, Thrombosis and Haemostasis.

[25]  R. Hoffman,et al.  Protein C Global Assay in the Evaluation of Women with Idiopathic Pregnancy Loss , 2002, Thrombosis and Haemostasis.

[26]  Tsung O Cheng,et al.  Could elevated C-reactive protein in patients with obstructive sleep apnea be due to obesity per se? , 2003, Circulation.

[27]  G. Lip,et al.  Virchow’s Triad Revisited: Blood Constituents , 2003, Pathophysiology of Haemostasis and Thrombosis.

[28]  A. Lee,et al.  Epidemiology and management of venous thromboembolism in patients with cancer. , 2003, Thrombosis research.

[29]  J. Heit,et al.  Risk factors for venous thromboembolism. , 2003, Clinics in chest medicine.

[30]  W. Schobersberger,et al.  Coagulation changes and edema formation during long-distance bus travel , 2004, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[31]  A. Kroon,et al.  The prothrombotic paradox of hypertension: role of the renin-angiotensin and kallikrein-kinin systems. , 2005, Hypertension.

[32]  G. Lip,et al.  Endothelial function and its assessment , 2005, Expert opinion on investigational drugs.

[33]  A. Ertl,et al.  Postural pseudoanemia: posture-dependent change in hematocrit. , 2005, Mayo Clinic proceedings.

[34]  C. Keenan,et al.  Age as a risk factor for venous thromboembolism after major surgery , 2005, Current opinion in pulmonary medicine.

[35]  F. Ataullakhanov,et al.  Initiation and propagation of coagulation from tissue factor‐bearing cell monolayers to plasma: initiator cells do not regulate spatial growth rate * , 2005, Journal of thrombosis and haemostasis : JTH.

[36]  Mikhail A Panteleev,et al.  Spatial propagation and localization of blood coagulation are regulated by intrinsic and protein C pathways, respectively. , 2006, Biophysical journal.

[37]  B. Mausbach,et al.  The role of stress hormones in the relationship between resting blood pressure and coagulation activity , 2006, Journal of hypertension.

[38]  K. Traynor Some Medicare Part D medication management programs will use pharmacists. , 2006, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[39]  B. Brenner,et al.  Evaluation of ProC Global assay in women with a history of venous thromboembolism on hormonal therapy , 2006, Thrombosis and Haemostasis.

[40]  E. Bjørklid,et al.  Sources of tissue factor. , 2006, Seminars in thrombosis and hemostasis.

[41]  D. Levy,et al.  Multiple biomarkers for the prediction of first major cardiovascular events and death. , 2006, The New England journal of medicine.

[42]  G. Oster,et al.  Risk of venous thromboembolism among hospitalized medically ill patients. , 2006, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[43]  P. Toulon,et al.  An abnormal ProC Global test result is associated with an increased risk of venous thromboembolism independent of test sensitivity for protein C pathway abnormalities , 2007, Thrombosis and Haemostasis.

[44]  B. Chong,et al.  Management of thromboembolism in hematologic malignancies. , 2007, Seminars in thrombosis and hemostasis.